These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8782251)

  • 21. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride].
    Fleckenstein AE; Pögün S; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):200-6. PubMed ID: 8858994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121.
    Staley JK; Boja JW; Carroll FI; Seltzman HH; Wyrick CD; Lewin AH; Abraham P; Mash DC
    Synapse; 1995 Dec; 21(4):364-72. PubMed ID: 8869167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain.
    Farde L; Halldin C; Müller L; Suhara T; Karlsson P; Hall H
    Synapse; 1994 Feb; 16(2):93-103. PubMed ID: 8197578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.
    Frost JJ; Rosier AJ; Reich SG; Smith JS; Ehlers MD; Snyder SH; Ravert HT; Dannals RF
    Ann Neurol; 1993 Sep; 34(3):423-31. PubMed ID: 8363363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo saturation kinetics of two dopamine transporter probes measured using a small animal positron emission tomography scanner.
    Hume SP; Brown DJ; Ashworth S; Hirani E; Luthra SK; Lammertsma AA
    J Neurosci Methods; 1997 Sep; 76(1):45-51. PubMed ID: 9334938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET study.
    Volkow ND; Fowler JS; Logan J; Gatley SJ; Dewey SL; MacGregor RR; Schlyer DJ; Pappas N; King P; wang GJ
    J Nucl Med; 1995 Jul; 36(7):1289-97. PubMed ID: 7790958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography.
    Halldin C; Farde L; Lundkvist C; Ginovart N; Nakashima Y; Karlsson P; Swahn CG
    Synapse; 1996 Apr; 22(4):386-90. PubMed ID: 8867033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates.
    Volkow ND; Fowler JS; Ding YS; Wang GJ; Gatley SJ
    Adv Pharmacol; 1998; 42():211-4. PubMed ID: 9327881
    [No Abstract]   [Full Text] [Related]  

  • 29. Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55.
    Coulter CL; Happe HK; Bergman DA; Murrin LC
    Brain Res; 1995 Sep; 690(2):217-24. PubMed ID: 8535839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain.
    Little KY; Kirkman JA; Carroll FI; Breese GR; Duncan GE
    J Neurochem; 1993 Dec; 61(6):1996-2006. PubMed ID: 8245956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration.
    Letchworth SR; Sexton T; Childers SR; Vrana KE; Vaughan RA; Davies HM; Porrino LJ
    J Neurochem; 1999 Nov; 73(5):1982-9. PubMed ID: 10537056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the dopamine transporter in nonhuman primate brain: homogenate binding, whole body imaging, and ex vivo autoradiography using [125I] and [123I]IPCIT.
    al-Tikriti MS; Zea-Ponce Y; Baldwin RM; Zoghbi SS; Laruelle M; Seibyl JP; Giddings SS; Scanley BE; Charney DS; Hoffer PB
    Nucl Med Biol; 1995 Jul; 22(5):649-58. PubMed ID: 7581176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and biological evaluation of iodine-125-IACFT: a selective SPECT agent for imaging dopamine transporter sites.
    Elmaleh DR; Fischman AJ; Shoup TM; Byon C; Hanson RN; Liang AY; Meltzer PC; Madras BK
    J Nucl Med; 1996 Jul; 37(7):1197-202. PubMed ID: 8965198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent.
    Kung MP; Stevenson DA; Plössl K; Meegalla SK; Beckwith A; Essman WD; Mu M; Lucki I; Kung HF
    Eur J Nucl Med; 1997 Apr; 24(4):372-80. PubMed ID: 9096087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT.
    Morris ED; Babich JW; Alpert NM; Bonab AA; Livni E; Weise S; Hsu H; Christian BT; Madras BK; Fischman AJ
    Synapse; 1996 Nov; 24(3):262-72. PubMed ID: 8923667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
    Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ
    Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of 3beta-(4-[18F]fluoromethylphenyl)- and 3beta-(2-[18F] fluoromethylphenyl)tropane-2beta-carboxylic acid methyl esters: new ligands for mapping brain dopamine transporter with positron emission tomography.
    Petric A; Barrio JR; Namavari M; Huang SC; Satyamurthy N
    Nucl Med Biol; 1999 Jul; 26(5):529-35. PubMed ID: 10473191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine.
    Gatley SJ; Volkow ND; Fowler JS; Dewey SL; Logan J
    Synapse; 1995 Jun; 20(2):137-44. PubMed ID: 7570343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
    Scheffel U; Pögün S; Stathis M; Boja JW; Kuhar MJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):954-8. PubMed ID: 2046028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly potent cocaine analogs cause long-lasting increases in locomotor activity.
    Fleckenstein AE; Kopajtic TA; Boja JW; Carroll FI; Kuhar MJ
    Eur J Pharmacol; 1996 Sep; 311(2-3):109-14. PubMed ID: 8891589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.